Quest Diagnostics Incorporated 2025-2026 Proxy Voting Records

Description as filed by funds: Election of Directors: Denise M. Morrison

Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Denise M. Morrison”): 89,808,461 for, 4,176,407 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 172 asset managers below reported 42,471,469 for, 26,945 against, 21,459 abstained, 93 not voted.

Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.

Description as filed by funds: Election of Directors: Gary M. Pfeiffer

Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Gary M. Pfeiffer”): 86,302,153 for, 7,716,970 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 172 asset managers below reported 42,255,608 for, 242,807 against, 21,457 abstained, 93 not voted.

Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.

Description as filed by funds: Election of Directors: James E. Davis

Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: James E. Davis”): 88,799,800 for, 5,237,756 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 172 asset managers below reported 42,339,937 for, 158,476 against, 21,456 abstained, 93 not voted.

Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.

Description as filed by funds: Election of Directors: Timothy L. Main

Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Timothy L. Main”): 88,302,767 for, 5,614,920 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 172 asset managers below reported 42,356,883 for, 72,656 against, 90,332 abstained, 93 not voted.

Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.

Description as filed by funds: Election of Directors: Timothy M. Ring

Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Timothy M. Ring”): 81,917,543 for, 11,994,424 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 172 asset managers below reported 41,988,058 for, 510,355 against, 21,460 abstained, 93 not voted.

Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.

Description as filed by funds: Election of Directors: Tracey C. Doi

Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Tracey C. Doi”): 93,649,938 for, 393,268 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 172 asset managers below reported 42,495,528 for, 2,886 against, 21,456 abstained, 93 not voted.

Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.

Description as filed by funds: Election of Directors: Wright L. Lassiter, III

Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Wright L. Lassiter, III”): 93,802,306 for, 223,154 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 172 asset managers below reported 42,495,530 for, 2,885 against, 21,457 abstained, 93 not voted.

Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.

Description as filed by funds: Election of Directors: Luis A. Diaz, Jr., M.D.

Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Luis A. Diaz, Jr., M.D.”): 93,909,369 for, 110,114 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 171 asset managers below reported 42,495,531 for, 2,882 against, 21,457 abstained, 93 not voted.

Showing the 25 largest of 171 asset managers. See all 171 in the interactive database.

Description as filed by funds: Election of Directors: Robert B. Carter

Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Robert B. Carter”): 93,821,069 for, 205,166 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 171 asset managers below reported 42,495,530 for, 2,884 against, 21,457 abstained, 93 not voted.

Showing the 25 largest of 171 asset managers. See all 171 in the interactive database.

Description as filed by funds: Election of Directors: Timothy C. Wentworth

Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Timothy C. Wentworth”): 93,427,490 for, 597,095 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 171 asset managers below reported 42,495,523 for, 2,892 against, 21,457 abstained, 93 not voted.

Showing the 25 largest of 171 asset managers. See all 171 in the interactive database.

Description as filed by funds: Election of Directors: Vicky B. Gregg

Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Vicky B. Gregg”): 83,814,387 for, 10,232,574 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 171 asset managers below reported 38,923,684 for, 3,574,729 against, 21,456 abstained, 93 not voted.

Showing the 25 largest of 171 asset managers. See all 171 in the interactive database.

Description as filed by funds: An advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 proxy statement.

Quest Diagnostics Incorporated’s own tally for this item (“The advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 Proxy Statement was approved by the following votes:”): 86,869,738 for, 7,152,448 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 Proxy Statement was approved by the following votes:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Quest Diagnostics Incorporated’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (31 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 167 managers: 41,978,079 for, 384,266 against, 21,457 abstained, 93 not voted, 77 mixed. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 758 managers: 49,850,609 for, 3,943,310 against, 4,303 abstained, 19,862 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratification of the appointment of our independent registered public accounting firm for 2026.

Quest Diagnostics Incorporated’s own tally for this item (“The ratification of the appointment of PricewaterhouseCoopers as the Company's independent registered public accounting firm for 2026 was approved by the following votes:”): 97,340,034 for, 5,809,995 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The ratification of the appointment of PricewaterhouseCoopers as the Company's independent registered public accounting firm for 2026 was approved by the following votes:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Quest Diagnostics Incorporated’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify PricewaterhouseCoopers LLP as Auditors” (5 managers, 121,814 for).

The 170 asset managers below reported 42,189,552 for, 187,149 against, 21,456 abstained, 93 not voted.

Showing the 25 largest of 170 asset managers. See all 170 in the interactive database.

Description as filed by funds: Stockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting.

Quest Diagnostics Incorporated’s own tally for this item (“The stockholder proposal regarding an independent board chairman was not approved by the following votes:”): 23,999,636 for, 69,792,819 against — failed, per its Form 8-K filed May 21, 2026 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “The stockholder proposal regarding an independent board chairman was not approved by the following votes:”
Support: 26% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 170 asset managers below reported 5,362,986 for, 37,015,750 against, 21,460 abstained, 93 not voted, 100 unknown.

Showing the 25 largest of 170 asset managers. See all 170 in the interactive database.